Phase 2 Spectra Study to Evaluate the Safety and Efficacy of OPL-0401 in Patients With Diabetic Retinopathy
Clinical trial NCT05393284 · UNKNOWN
Trial details
- NCT number
- NCT05393284
- Sponsor
- Valo Health, Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-16
- Primary completion
- 2024-08-01
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.